US Broker Ratings

Phreesia, Inc. (PHR) Stock Analysis: Unveiling a 74% Potential Upside in Health Information Services

Phreesia, Inc. (NYSE: PHR), a prominent player in the healthcare sector, is capturing investor attention with a striking potential upside of 74.20%, according to recent analyst ratings. Specializing in health..

Ligand Pharmaceuticals (LGND) Stock Analysis: Strong Buy Ratings and Significant Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a biopharmaceutical company, is rapidly becoming a focal point for investors, boasting a robust market capitalization of $3.78 billion. Known for its innovative development and..

Arcellx, Inc. (ACLX) Stock Analysis: A Biotech Innovator with 81.71% Potential Upside

Arcellx, Inc. (NASDAQ: ACLX), a notable player in the biotechnology sector, is making waves with its innovative approach to immunotherapy. Specializing in treatments for cancer and other incurable diseases, Arcellx’s..

PACS Group, Inc. (PACS) Stock Analysis: Unpacking a 31% Revenue Growth and 11% Potential Upside

PACS Group, Inc. (NASDAQ: PACS), a key player in the healthcare sector, has captured investor interest with its remarkable financial trajectory and robust growth prospects. Operating in the medical care..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A 32% Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology firm, is making waves in the healthcare sector with its focus on neuroscience and a promising pipeline of therapeutics targeting neurological and..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A 197% Upside Potential that Grabs Investor Attention

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a key player in the biotechnology sector, presents an intriguing investment opportunity for those looking to capitalize on the burgeoning field of rare and ultra-rare..

Disc Medicine, Inc. (IRON) Stock Analysis: Strong Buy Ratings and a Promising 54.73% Potential Upside

Disc Medicine, Inc. (NASDAQ: IRON) is capturing investor attention with its robust pipeline in the biotechnology sector, focusing on hematologic diseases. With a market capitalization of $2.97 billion, Disc Medicine..

Premier, Inc. (PINC) Stock Analysis: Navigating a Static Landscape with a 2.97% Dividend Yield

Investors eyeing Premier, Inc. (NASDAQ: PINC) might find themselves at a crossroads as the healthcare improvement company presents a mixed bag of financial metrics and stagnant price movements. With a..

Bausch Health Companies Inc. (BHC) Stock Analysis: A Closer Look at Its Potential in the Healthcare Sector

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector, has been capturing the attention of investors with its extensive range of products across various medical fields...

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a Potential 96% Upside in the Biotech Sector

For investors eyeing opportunities in the healthcare sector, Biohaven Ltd. (NASDAQ: BHVN) presents an intriguing proposition. As a biotechnology company focused on developing therapies for immunology, neuroscience, and oncology, Biohaven..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A 53% Potential Upside in the Surgical Robotics Arena

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a pioneering force in the healthcare sector, is captivating investor attention with its significant growth trajectory and innovative approach to medical device technology. Specializing in..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Unveiling a 10% Upside Potential Amidst Robust Revenue Growth

As Amneal Pharmaceuticals, Inc. (NYSE: AMRX) continues to make strategic strides in the healthcare sector, investors are keenly observing its trajectory. With a current market capitalization of $4 billion, Amneal..

National HealthCare Corporation (NHC) Stock Analysis: Navigating Growth in the Healthcare Sector

National HealthCare Corporation (NYSE: NHC) is an intriguing player in the healthcare sector, operating within the medical care facilities industry. Based in Murfreesboro, Tennessee, this company has established itself as..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Revenue Surge and Analyst Consensus Signal Opportunity

Arcutis Biotherapeutics, Inc. (ARQT), a promising player in the biotechnology sector focusing on dermatological treatments, has been making waves with its innovative product pipeline and remarkable revenue growth. With a..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: A Biotech Giant with 69.63% Potential Upside

Ascentage Pharma Group International (AAPG), a prominent player in the biotechnology sector, presents a compelling opportunity for investors seeking exposure to the burgeoning healthcare market in China. With a market..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

Harmony Biosciences Holdings (HRMY) Stock Analysis: A Revenue Growth Powerhouse with 25.66% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands out in the biotechnology sector, not just for its innovative portfolio but also for its compelling financial metrics and growth potential. With a..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: A Look at 178% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) presents an intriguing opportunity for investors willing to navigate the dynamic landscape of the biotechnology sector. With a market capitalization of $1.56 billion, this U.S.-based..

Tarsus Pharmaceuticals, Inc. (TARS)

⚠️ No article content returned.

..

Warby Parker Inc. (WRBY): Investor Outlook with a 13.26% Potential Upside

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector under the medical instruments and supplies industry, has captivated investor interest with a market cap of $2.84 billion...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds